Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation - Trial NCT06291922
Access comprehensive clinical trial information for NCT06291922 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Pennsylvania and is currently Not yet recruiting. The study focuses on Heart Failure. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Pennsylvania
Timeline & Enrollment
N/A
Mar 01, 2024
Jun 01, 2028
Primary Outcome
Effects of exercise intervention on physical activity and capacity (step count),Effects of exercise intervention on physical activity and capacity (distance)
Summary
The goal of this clinical trial is to evaluate the effects of a home-based exercise program
 using mobile technology on physical activity and capacity, frailty and muscle mass, and
 quality of life in patients with a newly implanted HeartMate 3 left ventricular assist device
 (HM3 LVAD). Researchers will compare the effects of an exercise intervention vs. usual care
 on physical activity and capacity, frailty and muscle mass, and quality of life.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06291922
Non-Device Trial